Trial Profile
A Phase 2b, Randomized, Double-Blind, Multi-Dose Efficacy, Safety and Dose-finding Study of the Oral Factor Xa Inhibitor DU-176b Compared With Placebo for Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty (STARS J-1).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms STARS J-1
- Sponsors Daiichi Sankyo Inc
- 30 Sep 2010 New trial record